Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

ISSN: 2211-5544 (Online)
ISSN: 2211-5552 (Print)


Volume 3, 3 Issues, 2014


Download PDF Flyer




Current Molecular Imaging

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Abass Alavi
Department of Radiology/Nuclear Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Molecular Imaging of Neuropsychiatry and Boron Neutron Capture Therapy in Neuro-oncology

Author(s): Chun-Kai Fang, Ya-Fang Chang, Hui-Yen Chuang and Jeng-Jong Hwang

Affiliation: Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan.

Abstract

Both neuropsychiatric disorders and malignancies of central nervous system (CNS) represent a significant health burden and life-threatening diseases worldwide. Radiotracer-based neuroimaging is an attractive tool that permits the in vivo detection and characterization of metabolic and molecular processes which are fundamental elements for brain function, and improves the theranostics of brain diseases and disorders.

In this review, we outlined the new development of molecular imaging probes for dopamine and serotonin systems in neuropsychiatry and boron neutron capture therapy (BNCT) for brain tumors in neuro-oncology with positron emission tomography (PET) and single-photon emission computed tomography (SPECT).


Keywords: Boron neutron capture therapy, dopamine, molecular imaging, positron emission tomography, serotonin, singlephoton emission computed tomography

Purchase Online Rights and Permissions

Article Details

Volume: 2
First Page: 1
Last Page: 12
Page Count: 12
DOI: 10.2174/15748855113089990013
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science